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Modulatory Effects of GABA(B) Receptor Facilitation in a Model of Chronic
Inﬂammation!
Michael A. Langhardt, McNair Scholar, Biological Sciences Major!
Jefferson W. Kinney, Faculty Mentor !
Behavioral Neuroscience Laboratory, Department of Psychology, University of Nevada Las Vegas!

INTRODUCTION!

Inﬂammation within the brain (neuroinﬂammation) has been associated with a number of
neurodegenerative diseases, including Alzheimerʼs disease (AD) (Solito et al., 2012). Within the brain,
inﬂammation is deﬁned broadly as prolonged activation of the brainʼs immune cells, known as glial
cells. Excessive activation of glial cells within the brains of AD patients is a hallmark of the disease,
however the mechanism by which this contributes to disease pathology is relatively unclear (Jo et al.,
2014). Recently, studies have shown that glial cells, known as astrocytes, are able to synthesize and
release the inhibitory neurotransmitter GABA (Charles et al., 2003). Further, microglia cells, the primary
immunocompetent cells of the brain, have been shown to be GABAceptive cells, which express GABA
(B) type receptors (Kuhn et al., 2004). Early characterizations of AD ﬁrst described alterations in
astrocyte location and activation in the disease and interestingly, differences in the total abundance of
GABA within the brains of AD patients have recently been reported. Combined, these data provide
support for the hypothesis that astrocytes regulate microglia activity through the release of GABA acting
at GABA(B) type receptors. The activation of GABA(B) on microglia may serve to reduce the activation
status of these microglia, thereby reducing the number of pro-inﬂammatory cytokines present within the
brain (Streit et al., 2002). In the present study, we examined the effects of the GABA(B) agonist
baclofen on chronic inﬂammation in rodents administered lipopolysaccharide (LPS). LPS is a bacterial
endotoxin derived from the cell wall of gram-negative bacteria and is capable of mounting an immune
response through the activation of toll-like receptor 4 (TLR4). Our data indicate that the administration
of baclofen initially attenuated the pyrogenic effects of LPS administration, though this effect was lost
after two weeks of injections. The administration of baclofen also rescued deﬁcits in spatial learning and
memory seen in animals chronically administered LPS. Furthermore, a signiﬁcant increase in the total
abundance of AB oligomers, believed to play a role in the pathology of AD, was seen in the brains of
animals chronically administered LPS. Together, these data provide evidence that the modulation of
GABA(B) receptor function altered the immune response evoked by activation of TLR4. These data
also provide support for a potential role of GABA(B) in modulating aberrant immune activity seen in AD
populations.!

EXPERIMENTAL PROCEDURE!

Subjects:!
30 male Sprague Dawley rodents (n=30) were used in this experiment. Subjects were divided into three
groups (n=10/group) and randomly assigned to one of three treatment schedules: Saline-Saline
(control), LPS-Saline (LPS), or LPS-Baclofen (LPS-Bac). All animals were individually housed in a
standard animal facility with a 12-12 hour light, dark cycle with food and water available ad libitum
throughout the course of the experiment. All procedures were performed in accordance with the
institutional Animal Care and Use Committee and NIH guidelines. !

RESULTS!

Administration of baclofen attenuated the pyrogenic effects of chronic LPS.!

In the Morris water task probe trial, all groups spent signiﬁcantly more
time in the target quadrant. Only controls showed a signiﬁcant increase
in the number of annulus crossings.!

Figure 1. Mean temperatures immediately prior to injections and at 1, 2, and 3 post-injection day intervals. (*p < 0.05 compared to
controls). Error bars denoted as ± Standard Error of Mean (SEM).

Administration of baclofen rescued LPS-induced deﬁcits in learning and memory in
the Morris water task. No differences were seen in visible performance, speed or
percent thigmotaxis between animals.!

Figure 3. Mean proportion of time in quadrant and average number of annulus crossings (±SEM) during the probe trial. (*p <
0.05 compared to controls)!

Total Aβ oligomeric protein levels were signiﬁcantly elevated in animals
administered LPS. No differences were seen between LPS and LPS-Bac
animals. !

Drug Administration:!
As part of a larger experiment, stereotaxic surgeries were performed on all animals under aseptic
conditions and ketamine/dexmedatomidine anesthesia. 8mL of artiﬁcial cerebrospinal ﬂuid (ACSF) was
slowly infused into each lateral ventricle using the stereotaxic coordinates 0.7mm posterior, 1.4mm
lateral to Bregma, and 3.5 mm ventral to the surface of the skull. Following a recovery period of one
week after surgeries, animals received intraperitoneal (i.p) injections of LPS (0.5mg/mL/kg) or saline
(1mL/kg) twice a week for seven weeks for a total of 14 injections. Four hours following LPS or Saline
injections, animals received i.p. injections of baclofen (1mg/mL/kg) or saline (1mL/kg) resulting in the
three treatment groups: Saline-Saline (control), LPS-Saline (LPS), and LPS-Baclofen (LPS-Bac).!
Temperatures:!
To ensure an immune response was evoked by the administration of LPS, rectal temperatures were
tracked prior to drug administration and at 1, 2, and 3-day intervals post injection throughout the course
of the experiment. Following the last injection, animals were given three weeks for temperatures to
return to baseline prior to behavioral testing. !

Figure 4. Protein levels proportion to control (±SEM) in hippocampal tissue collected from animals. (* p < 0.05)
Representative Western Blot image. !

CONCLUSION!
Ø Baclofen attenuated the pyrogenic response evoked through the
administration of LPS .!

Morris Water Task:!
The Morris water task was conducted in a white circular tank, 1.8 m in diameter, 75 cm in height, and
4.7 mm in thickness. To mask the hidden platform, each morning the water was made opaque with the
addition of white non-toxic paint. For each subject, a 10cm x 10cm square platform was placed in the
center of one of the four quadrants of the tank, 1.5 cm below the water. At the start of each trial, rats
were placed into the maze and given sixty seconds to ﬁnd the hidden platform located below the
surface of the water. If after sixty seconds the animal was unsuccessful in locating the hidden platform,
a trained experimenter guided the animal to the hidden platform. Once reaching the platform, animals
were given twenty seconds to orient themselves to the distal spatial cues. Each animal performed four
trials for each day of experimental testing. Twenty-four hours after the control group reached an
average latency of ten seconds, a single probe trial was conducted in which the platform was removed
from the maze and selective search behavior was recorded for each animal. Following the probe trial,
two days of visible training in which the hidden platform was replaced with a visible platform were
conducted in order to detect any visual or motor deﬁcits. !
SDS Page/Western Blot:!
Tissue was prepared for western blotting as previously described (Sabbagh et al., 2013). For each
sample, 20 micrograms of protein were loaded at 10% SDS-PAGE gels and proteins were separated by
molecular weight through electrophoresis. Proteins were then transferred to nitrocellulose membranes
and blocked in a solution of 5% milk to prevent non-speciﬁc antibody binding. Following blocking,
membranes were incubated overnight in primary antibody (rabbit Aβ, 1:1000, Cell Signaling; mouse βactin, 1:20000, ProteinTech) at 4°C. Following overnight incubation, membranes were washed and
placed into secondary antibody solution (IR dye anti-rabbit 800, 1:5000, Li-Cor; IR dye anti-mouse 680,
1:10000, LiCor) for 2 hours. Membranes were imaged using the Odyssey CLx Infrared Imaging System
and band intensity was obtained for each target of interest. Each sample was run in duplicate with βactin to normalize protein levels. !

Ø Baclofen rescued learning and memory deﬁcits seen in animals
administered LPS.!
Ø LPS and LPS-Bac animals show a signiﬁcant increase in total Aβ
oligomeric protein levels. !
Ø Combined, these data provide support for the role of the GABA (B)
receptor in modulating chronic neuroinﬂammation. !
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